IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Overall, surgical de-escalation in gynecologic oncology increased from 2004 to 2020, with a growing shift toward minimally ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...

Improved education on drug toxicity management, especially within the first 90 days of treatment and regarding individualized ...

Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and familial ...

High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...

A major annual cancer report has revealed a mix of good news and points of concern. Cancer diagnoses are expected to exceed ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

A nurse, foster mom and the primary provider for a family of eight, Shelly Sepulveda has devoted her life to taking care of ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...